USNA
Income statement / Annual
Last year (2024), USANA Health Sciences, Inc.'s total revenue was $854.50 M,
a decrease of 7.22% from the previous year.
In 2024, USANA Health Sciences, Inc.'s net income was $42.03 M.
See USANA Health Sciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/28/2024 |
12/30/2023 |
12/31/2022 |
01/01/2022 |
01/02/2021 |
12/28/2019 |
12/29/2018 |
12/30/2017 |
12/31/2016 |
01/02/2016 |
| Operating Revenue |
$854.50 M |
$921.01 M |
$998.60 M |
$1.19 B |
$1.13 B |
$1.06 B |
$1.19 B |
$1.05 B |
$1.01 B |
$918.50 M |
| Cost of Revenue |
$161.21 M
|
$176.69 M
|
$193.89 M
|
$217.90 M
|
$209.11 M
|
$187.50 M
|
$200.71 M
|
$179.40 M
|
$180.19 M
|
$159.68 M
|
| Gross Profit |
$693.29 M
|
$744.32 M
|
$804.71 M
|
$968.57 M
|
$925.53 M
|
$873.40 M
|
$988.54 M
|
$867.86 M
|
$825.89 M
|
$758.82 M
|
| Gross Profit Ratio |
0.81
|
0.81
|
0.81
|
0.82
|
0.82
|
0.82
|
0.83
|
0.83
|
0.82
|
0.83
|
| Research and Development Expenses |
$0.00
|
$11.45 M
|
$11.56 M
|
$11.11 M
|
$10.63 M
|
$10.26 M
|
$10.24 M
|
$8.95 M
|
$8.84 M
|
$6.42 M
|
| General & Administrative Expenses |
$263.27 M
|
$256.99 M
|
$262.30 M
|
$279.11 M
|
$261.19 M
|
$267.73 M
|
$275.06 M
|
$265.09 M
|
$234.19 M
|
$209.00 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$434.79 M
|
$519.27 M
|
$487.86 M
|
$459.48 M
|
$525.13 M
|
$470.26 M
|
$453.08 M
|
$408.16 M
|
| Selling, General & Administrative Expenses |
$263.27 M
|
$256.99 M
|
$697.10 M
|
$798.37 M
|
$749.04 M
|
$727.21 M
|
$800.19 M
|
$735.36 M
|
$687.27 M
|
$617.16 M
|
| Other Expenses |
$363.70 M
|
$382.81 M
|
$1.01 M
|
$450,000.00
|
$1.46 M
|
$4.31 M
|
$3.16 M
|
$2.14 M
|
-$70,000.00
|
$927,000.00
|
| Operating Expenses |
$626.97 M
|
$651.25 M
|
$697.10 M
|
$798.37 M
|
$749.04 M
|
$727.21 M
|
$800.19 M
|
$735.36 M
|
$687.27 M
|
$617.16 M
|
| Cost And Expenses |
$626.97 M
|
$827.94 M
|
$890.99 M
|
$1.02 B
|
$958.15 M
|
$914.71 M
|
$1.00 B
|
$914.76 M
|
$867.46 M
|
$776.84 M
|
| Interest Income |
$11.32 M
|
$9.64 M
|
$3.79 M
|
$2.52 M
|
$2.54 M
|
$4.71 M
|
$4.43 M
|
$2.19 M
|
$1.48 M
|
$1.12 M
|
| Interest Expense |
$281,000.00
|
$262,000.00
|
$192,000.00
|
$57,000.00
|
$507,000.00
|
$66,000.00
|
$36,000.00
|
$46,000.00
|
$444,000.00
|
$15,000.00
|
| Depreciation & Amortization |
$22.23 M
|
$20.40 M
|
$21.41 M
|
$22.19 M
|
$22.51 M
|
$22.79 M
|
$16.73 M
|
$15.96 M
|
$13.48 M
|
$9.98 M
|
| EBITDA |
$98.86 M |
$123.11 M |
$130.22 M |
$192.89 M |
$200.96 M |
$146.19 M |
$188.35 M |
$132.50 M |
$152.10 M |
$151.64 M |
| EBITDA Ratio |
0.12
|
0.13
|
0.13
|
0.16
|
0.18
|
0.14
|
0.16
|
0.13
|
0.15
|
0.17
|
| Operating Income Ratio |
0.08
|
0.1
|
0.11
|
0.14
|
0.16
|
0.14
|
0.16
|
0.13
|
0.14
|
0.15
|
| Total Other Income/Expenses Net |
$10.03 M
|
$9.38 M
|
$1.01 M
|
$450,000.00
|
$1.46 M
|
$4.31 M
|
$3.16 M
|
$2.14 M
|
-$70,000.00
|
$927,000.00
|
| Income Before Tax |
$76.35 M
|
$102.45 M
|
$108.62 M
|
$170.64 M
|
$177.95 M
|
$150.50 M
|
$191.51 M
|
$134.64 M
|
$138.55 M
|
$142.59 M
|
| Income Before Tax Ratio |
0.09
|
0.11
|
0.11
|
0.14
|
0.16
|
0.14
|
0.16
|
0.13
|
0.14
|
0.16
|
| Income Tax Expense |
$34.29 M
|
$38.67 M
|
$39.27 M
|
$54.14 M
|
$53.28 M
|
$49.97 M
|
$65.29 M
|
$72.11 M
|
$38.51 M
|
$47.92 M
|
| Net Income |
$42.03 M
|
$63.79 M
|
$69.35 M
|
$116.51 M
|
$124.66 M
|
$100.53 M
|
$126.22 M
|
$62.54 M
|
$100.04 M
|
$94.67 M
|
| Net Income Ratio |
0.05
|
0.07
|
0.07
|
0.1
|
0.11
|
0.09
|
0.11
|
0.06
|
0.1
|
0.1
|
| EPS |
2.2 |
3.31 |
3.6 |
5.78 |
5.89 |
4.44 |
5.36 |
2.6 |
4.09 |
3.71 |
| EPS Diluted |
2.19 |
3.3 |
3.59 |
5.73 |
5.86 |
4.41 |
5.12 |
2.53 |
3.99 |
3.59 |
| Weighted Average Shares Out |
$19.06 M
|
$19.25 M
|
$19.25 M
|
$20.15 M
|
$21.16 M
|
$22.64 M
|
$23.57 M
|
$24.02 M
|
$24.49 M
|
$24.98 M
|
| Weighted Average Shares Out Diluted |
$19.16 M
|
$19.35 M
|
$19.31 M
|
$20.34 M
|
$21.26 M
|
$22.82 M
|
$24.64 M
|
$24.71 M
|
$25.05 M
|
$26.35 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
